Chimera Investment (CIM) Q4 2025 earnings review
Transformation Delivers: Earnings Surge Drives Dividend Hike
Chimera's strategic pivot to a hybrid mortgage REIT is validating itself faster than expected. Q4 Earnings Available for Distribution (EAD) surged to $0.53 per share, easily covering the $0.37 dividend, driven by the immediate accretion from the HomeXpress acquisition. Management signaled high confidence by raising the Q1 2026 dividend by 22% to $0.45. However, the legacy portfolio remains a drag on asset value: GAAP Book Value declined 2.7% to $19.70, resulting in a negative economic return of (0.9%) for the quarter despite the operational success.
🐂 Bull Case
The HomeXpress acquisition is not a 'fixer-upper'; it is performing immediately. The segment contributed $11 million in EBTDA and $0.10-$0.15 of incremental earnings power in its first full quarter, validating the hybrid model.
After quarters of tight coverage (1.0x in Q3), coverage expanded dramatically to 1.4x in Q4. The Board's decision to hike the payout to $0.45 indicates they view the new earnings baseline as durable.
🐻 Bear Case
Despite operational wins, GAAP Book Value fell 2.7% to $19.70, marking the third consecutive quarterly decline. High interest rates continue to pressure the legacy portfolio valuations, leading to a negative economic return of -0.9% for the quarter.
The quality of earnings remains complex. While EAD was $45 million, GAAP Net Income was only $7 million ($0.08/share). The massive gap is driven by unrealized losses and derivatives, obscuring the true economic picture for conservative investors.
⚖️ Verdict: 🟢
Bullish. The 22% dividend hike is the loudest signal management could send. While book value erosion is a nuisance, the successful integration of HomeXpress has structurally repaired the company's earnings power.
Key Themes
Residential Origination Engine Firing
Accelerating. The new Residential Origination segment (HomeXpress) is growing rapidly. Funded volume reached $1.04 billion in Q4, up 18% sequentially and 49% YoY. More importantly, it generated a 16.2% annualized EBTDA Return on Equity. This segment has transformed Chimera from a passive bond holder into an active mortgage manufacturer.
Book Value Bleed
Decelerating. Book value dropped from $20.24 to $19.70 (-2.7%) in Q4. While management pivoted to a hybrid model to protect earnings, the legacy investment portfolio (Non-Agency RMBS and securitized debt) remains sensitive to spread widening. Until this stabilizes, total economic return will lag the dividend yield.
Capital Recycling Efficiency
Stable. Chimera continues to grind out value from its balance sheet. In Q4, they exercised call rights on the CIM 2022-I1 securitization, sold $166M of loans, and generated $28M in net capital. They also sold $33M of legacy RMBS at a breakeven ROE to release capital. This recycling is critical to funding the higher-return Origination segment without raising dilutive equity.
Leverage Profile Shift
Accelerating. Recourse leverage has doubled from 1.2x a year ago to 2.4x in 25Q4. This reflects the shift toward carrying more Agency MBS (now $3.46B vs $519M a year ago) and the consolidation of HomeXpress. While 2.4x is manageable, the risk profile has fundamentally shifted from a low-leverage credit story to a more levered hybrid model.
Expense Creep from Integration
Accelerating. Compensation expense jumped to $18.2M in Q4 for the origination segment alone, and total company compensation hit $56.7M for FY25 vs $41.3M in FY24. While revenue is growing, the overhead of running an operating company (vs. a portfolio) introduces operational margin risk if volumes falter.
Other KPIs
Accelerating. Up from $0.37 in the prior three quarters. This is the key metric for REIT investors, and the breakout suggests the HomeXpress acquisition is highly accretive.
Accelerating. This segment was non-existent a year ago. It now generates more GAAP net income than the entire Investment Portfolio (which lost $2M in Q4 on a GAAP basis).
Accelerating. Up from 2.0x in Q3 and 1.2x in 24Q4. The balance sheet is working harder, primarily due to the addition of Agency MBS and warehouse lines for origination.
Guidance
Accelerating. Management explicitly stated expectation to maintain $0.45 per share for the remainder of 2026. This implies a 21.6% increase over the 2025 level ($0.37).
Accelerating. Q4 annual run rate is ~$4.1B, so this guidance implies sustaining the current record pace throughout 2026.
Stable. The midpoint ($71M) is roughly in line with the annualized Q4 run-rate ($15-18M/quarter x 4). Management is guiding for stability at these elevated levels rather than massive further growth.
Stable. Consistent with the 19-23% realized in Q4. This confirms the acquisition target metrics are being met.
Key Questions
Sustainability of Origination Margins
Gain-on-sale margins were strong in Q4 (3.58%). With rates volatile and competition heating up in Non-QM, is the 103.3-103.4 pricing assumption in the 2026 guidance conservative or aggressive?
Book Value Floor
Book value has shed ~7% since Q1. At what point does the mark-to-market pressure on the legacy portfolio abate, or should investors expect continued erosion as a 'cost' of the high dividend?
Agency MBS Strategy
The Agency portfolio ballooned to $3.5B. Is this a temporary parking spot for liquidity, or a permanent shift in capital allocation that will structurally increase leverage long-term?